A total of 60 patients diagnosed with CRC were investigated using qRT-PCR for the assessment of three specific CSC gene expression levels: PROM1/CD133, ALCAM/CD166, and HCAM/CD44. The gene discussed is CD44; the disease is colorectal carcinoma.